Compugen Ltd. (USA) (NASDAQ:CGEN)
A biotechnology discovery company focused on discovering and licensing of product candidates to the drug and diagnostic industry.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
new silicon-driven system for drug discovery. Focused on high return sectors.
Recs
Still early in development. flow.Negative cash
Recs
StockTA 1/25 Overall Bullish. Hold for 2 years.
Recs
great management and scientists
Recs
Gilder pick ... the future of pharma development in-silico
Recs
in the Big Short one investor talked about investing a little to make a lot. in 28yrs of serious investing i've never seen a better risk/reward if one has risk capital. CGEN is not looking to make a drug winner but to make time to market of future drugs significantly less. See George Gilders latest comments.
Recs
The breakthrough scientific company. The new paradigm of the drug discovery platform
Recs
its technologyand sound management of finances
Recs
Show me the money!
Recs
With the cancer drug + the Pfizer connection, this company has only upwards to go.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 10 of 10